Previous close | 82.17 |
Open | 82.33 |
Bid | 80.88 x 500 |
Ask | 80.96 x 500 |
Day's range | 80.90 - 83.09 |
52-week range | 76.02 - 99.56 |
Volume | |
Avg. volume | 1,533,565 |
Market cap | 15.355B |
Beta (5Y monthly) | 0.32 |
PE ratio (TTM) | 76.33 |
EPS (TTM) | 1.06 |
Earnings date | 24 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 110.10 |
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript April 24, 2024 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.6. BioMarin Pharmaceutical Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name […]
BioMarin Pharmaceutical ( NASDAQ:BMRN ) First Quarter 2024 Results Key Financial Results Revenue: US$648.8m (up 8.8...
BioMarin's (BMRN) earnings beat estimates in the first quarter of 2024, while revenues slightly miss the mark. The company maintains revenue guidance for 2024.